R&D
In vitro gametogenesis: the science has to be right, and it has to be safe
In vitro gametogenesis (IVG) holds much potential for same-sex …
14 May, 2024
18815 items found
News
Bayer cutbacks start to be felt with 1,500 jobs shed in Q1
Bayer’s first-quarter results update shows that its workforce has …
14 May, 2024
News
Semaglutide heart benefits may go beyond weight loss
New data suggests that the benefits of Novo Nordisk’s GLP-1 agonist …
14 May, 2024
Sales & Marketing
Sponsored
12 Questions with Michael Stevinson
Michael Stevinson is Global Agency Head at Caudex, an IPG Health …
14 May, 2024
News
Cytokinetics prepares to take on BMS’ Camzyos in HCM
Cytokinetics has revealed the results from a phase 3 trial of its …
14 May, 2024
Patients
Beyond distance and stigma: AI's potential to democratise healthcare
Access to healthcare and health information remains vastly unequal, …
15 May, 2024
Digital
Is digital therapeutics innovation enough for a sustainable future?
Treatments emerging from the digital therapeutics space were once …
14 May, 2024
News
MSD has another TIGIT programme setback
A phase 3 trial of MSD’s anti-TIGIT antibody vibostolimab and PD-1 …
14 May, 2024
News
Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot
Takeda has made a strong play for a stake in the Alzheimer’s disease …
13 May, 2024
News
Wearable device ‘may prevent heart failure hospitalisation’
Monitoring of heart failure patients in their homes using a wearable …
13 May, 2024
News
Sanofi to invest €1bn in France to lift ‘health sovereignty’
Sanofi will invest more than €1 billion ($1.08 billion) in new …
13 May, 2024
Market Access
Who delays NICE technology appraisals anyway?
Leela Barham looks at the speediness of NICE’s technology appraisals …
13 May, 2024